SS18 and synovial sarcoma: The most common molecular alterations (excluding canonical SS18::SSX fusions in synovial sarcoma) involved ATM (18%), ARID1A (9%), CTNNB1 (9%), PALB2 (9%), and NF1 (9%), while 46% of profiled cases showed no detectable alterations.